The National Cancer Institute (NCI) has renewed the comprehensive designation for the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, granting the center an additional five years of support and $18 million in grant funding. This renewal underscores the center’s commitment to advancing cancer research and care, recognizing its extensive clinical and basic science research, as well as its service to diverse communities.
As one of only three NCI-designated comprehensive cancer centers in Texas, the Duncan Cancer Center first received its NCI designation in 2007 and achieved comprehensive status in 2014. Over the years, the center has expanded significantly, now boasting 278 faculty members and research funding that exceeds $148 million, with more than $43 million sourced from the NCI.
Advancements in Cancer Care
In the past five years, the Duncan Cancer Center has made significant strides in improving cancer care. Notable accomplishments include the implementation of lung cancer screenings aimed at early disease detection, the launch of the nation’s first cell therapy unit within a safety net hospital, and the introduction of innovative tools for rapid cancer diagnosis during surgical procedures.
“Our center is driven by the needs of our patients and community to pursue scientific breakthroughs that will reduce cancer burden for all,” stated Dr. Pavan Reddy, director of the Duncan Cancer Center. This patient-focused approach emphasizes the center’s commitment to not only advancing research but also enhancing the quality of care provided to those affected by cancer.
In the upcoming five years, leadership at the center aims to expedite the translation and implementation of research findings into clinical practice. Their goals include providing innovative, personalized care, improving access to top-tier cancer treatment across the community and state, and fostering the development of future leaders in cancer research and clinical care.
Community Impact and Outreach
The physicians at the Duncan Cancer Center deliver patient care at multiple facilities affiliated with Baylor, situated within the Texas Medical Center. These include Baylor St. Luke’s Medical Center, Texas Children’s Hospital, Ben Taub Hospital, and the Michael E. DeBakey Veteran’s Affairs Medical Center. The center’s catchment area spans Harris County and eight surrounding counties, serving nearly 8 million people.
A key component of the center’s mission is to provide comprehensive cancer services and education, particularly to underserved populations within this region.
“The faculty in the Duncan Cancer Center are leaders in their field. With this renewed funding, they will continue to make advancements in cancer research and care that benefit people in Houston and around the world,” remarked Dr. Paul Klotman, president, CEO, and executive dean of Baylor.
The renewal of the NCI designation not only solidifies the Duncan Cancer Center’s reputation as a leader in cancer research and treatment but also reinforces its commitment to enhancing the health and well-being of the communities it serves.
